446 related articles for article (PubMed ID: 35454762)
1. Advances in the Immunomodulatory Properties of Glycoantigens in Cancer.
da Costa V; Freire T
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454762
[TBL] [Abstract][Full Text] [Related]
2. Glycans in melanoma: Drivers of tumour progression but sweet targets to exploit for immunotherapy.
Niveau C; Sosa Cuevas E; Saas P; Aspord C
Immunology; 2024 May; ():. PubMed ID: 38742251
[TBL] [Abstract][Full Text] [Related]
3. Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens.
Khilji SK; Op 't Hoog C; Warschkau D; Lühle J; Goerdeler F; Freitag A; Seeberger PH; Moscovitz O
Theranostics; 2023; 13(9):3041-3063. PubMed ID: 37284439
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
Hakomori S
Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
[TBL] [Abstract][Full Text] [Related]
5. Altered Glycosylation in Progression and Management of Bladder Cancer.
Wilczak M; Surman M; Przybyło M
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110670
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors.
Matsumoto Y; Ju T
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509200
[TBL] [Abstract][Full Text] [Related]
7. The effect of a methyl group on structure and function: Serine vs. threonine glycosylation and phosphorylation.
Barchi JJ; Strain CN
Front Mol Biosci; 2023; 10():1117850. PubMed ID: 36845552
[TBL] [Abstract][Full Text] [Related]
8. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
[TBL] [Abstract][Full Text] [Related]
9. Targeting Aberrant Sialylation to Treat Cancer.
Munkley J; Scott E
Medicines (Basel); 2019 Oct; 6(4):. PubMed ID: 31614918
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
[TBL] [Abstract][Full Text] [Related]
11. Implications of altered O-glycosylation in tumour immune evasion.
Itano N
J Biochem; 2019 May; 165(5):387-390. PubMed ID: 30649348
[TBL] [Abstract][Full Text] [Related]
12. Various Tastes of Sugar: The Potential of Glycosylation in Targeting and Modulating Human Immunity via C-Type Lectin Receptors.
Busold S; Nagy NA; Tas SW; van Ree R; de Jong EC; Geijtenbeek TBH
Front Immunol; 2020; 11():134. PubMed ID: 32117281
[TBL] [Abstract][Full Text] [Related]
13. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.
Cornelissen LA; Van Vliet SJ
Biomolecules; 2016 May; 6(2):. PubMed ID: 27153100
[TBL] [Abstract][Full Text] [Related]
14. Cell surface glycan-lectin interactions in tumor metastasis.
Rambaruth ND; Dwek MV
Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
[TBL] [Abstract][Full Text] [Related]
15. Role of protein glycosylation in cancer metastasis.
Oliveira-Ferrer L; Legler K; Milde-Langosch K
Semin Cancer Biol; 2017 Jun; 44():141-152. PubMed ID: 28315783
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.
Berois N; Pittini A; Osinaga E
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158915
[TBL] [Abstract][Full Text] [Related]
17. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer.
Cagnoni AJ; Pérez Sáez JM; Rabinovich GA; Mariño KV
Front Oncol; 2016; 6():109. PubMed ID: 27242953
[TBL] [Abstract][Full Text] [Related]
18. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
19. Altered N-Glycan expression profile in epithelial-to-mesenchymal transition of NMuMG cells revealed by an integrated strategy using mass spectrometry and glycogene and lectin microarray analysis.
Tan Z; Lu W; Li X; Yang G; Guo J; Yu H; Li Z; Guan F
J Proteome Res; 2014 Jun; 13(6):2783-95. PubMed ID: 24724545
[TBL] [Abstract][Full Text] [Related]
20. The tumour glyco-code as a novel immune checkpoint for immunotherapy.
RodrÍguez E; Schetters STT; van Kooyk Y
Nat Rev Immunol; 2018 Mar; 18(3):204-211. PubMed ID: 29398707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
